$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge
Robots for this group tickers :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) - 30-day Annualized Return +209%
Swing Trader, Popular Stocks: Price Action Trading Strategy - Pro Version (TA&FA) - 30-day Annualized Return +182%
Recently, Women's Health companies have taken center stage, showcasing a remarkable +14.83% increase in performance over the past week. This surge is backed by three key players in the sector - AWH (Aspira Women's Health), AGRX (Agile Therapeutics), and RDUS (Radius Health).
Positive Outlook and Volume Indicators: Today, stocks in the Women's Health group maintain a positive outlook, supported by robust Volume Indicators. Tickeron, a leading market analysis platform, predicts a further increase of over 4.00% within the next month, with a 63% likelihood. The daily ratio of advancing to declining volumes in the past month was an impressive 4.35 to 1.
Advances Indicator and Positive Trends: A closer look at the Advances Indicator reveals a consistent positive trend across three stocks in this thematic group, with an average likelihood of 82%. This suggests a prevailing sentiment of growth and stability among investors.
Market Capitalization Insights: The market capitalization within the Women's Health Theme averages at 245.7M. RDUS stands out with the highest valuation in this group, reaching an impressive 697.4M. In contrast, AGRX holds the position of the lowest valued company at 5.2M.
Price Movements: Weekly, the average price growth for all stocks in the Women's Health Theme was a significant 14.83%. AWH spearheaded this growth with a remarkable 43.89% increase, while AGRX experienced a notable dip at -2.99%. The monthly and quarterly averages stood at 10.55% and -4.59%, respectively.
Notable News and Price Movements:
- AWH made headlines as the top weekly gainer, rising by 26.79% on 8/15/23, and also faced a significant drop of -36.68% on 7/27/23.
- AGRX, on 10/7/23, saw a sharp decline of -20.83%, marking it as a top weekly loser.
- RDUS, on 12/26/23, continued an uptrend, experiencing a +22% increase during the month of 11/22/23 - 12/26/23.
Volume Growth: While the average weekly volume growth across all stocks in the Women's Health Theme was -1.08%, monthly and quarterly figures painted a different picture with 164.37% and 19.64% growth, respectively. Notable record-breaking daily volume increases were observed for AWH, AGRX, and RDUS, emphasizing heightened market activity.
Technical Analysis Highlights:
-
AWH: The 50-day moving average crossed bearishly below the 200-day moving average on December 11, 2023. Despite this, the stock has shown resilience, with a recent uptrend of +28% during the week of 12/18/23 - 12/26/23.
-
AGRX: The RSI Oscillator for AGRX moved out of the overbought zone on December 05, 2023, suggesting a potential shift from an upward to a downward trend. The odds of a move down, according to Tickeron's analysis, stand at 90%.
-
RDUS: Displaying a +1.52% uptrend, RDUS advanced for three consecutive days on December 26, 2023. Historical data indicates a 75% likelihood of continued upward momentum.
Summary: The Women's Health sector, led by AWH, AGRX, and RDUS, is currently in a phase of dynamic growth, supported by positive market indicators and technical analyses. Investors should keep a keen eye on these stocks, considering the theme's potential for further expansion in the coming months.
AWH in upward trend: price may jump up because it broke its lower Bollinger Band on September 11, 2024
AWH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where AWH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a company, which engages in the provision of bio-analytic and diagnostic services and helps physicians diagnose, treat, and improve gynecologic health outcomes for women
Industry MedicalSpecialties